Keywords: Perrigo, Rosemont Pharma, M&A, Specialty and generic Rx drugs
Perrigo acquires UK drugmaker Rosemont for £180 million
Article | 12 February 2013
USA-based Perrigo (Nasdaq: PRGO) has signed a definitive merger agreement and has completed the acquisition of Leeds, UK-based Rosemont Pharmaceuticals ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
